SCHEMBL4869343

SCHEMBL4869343

CC(=O)c1cc(Cl)cnc1N

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.39
SCN2A Q99250 1/20 0.39
SCN3A Q9NY46 1/20 0.39
SCN10A Q9Y5Y9 1/20 0.39
MAP4K4 O95819 5/20 0.39
MAPK1 P28482 1/20 0.38
CHRNA7 P36544 4/20 0.38
PTK2 Q05397 1/20 0.37
IDO1 P14902 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
PIK3CB P42338 1/20 0.36
RAB9A P51151 2/20 0.36
MAPT P10636 1/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
HPGD P15428 1/20 0.36
CYP3A4 P08684 1/20 0.36
IKBKE Q14164 1/20 0.36
TBK1 Q9UHD2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31382687 1.00 SCN9A (0.39) SCN9ASCN2ASCN3ASCN10AMAP4K4
SCHEMBL1013695 0.82 PIK3CB (0.47) MAP4K4IDO1PIK3CBKDM4E
SCHEMBL1319218 0.82 CYP3A4 (0.50) MAP4K4SMN1; SMN2RAB9AMAPTKDM4E
SCHEMBL11555230 0.82 MAP4K4 (0.40) SCN9ASCN2ASCN3ASCN10AMAP4K4
Hydrochloric Acid SCHEMBL11549048 0.81 CYP3A4 (0.48) MAP4K4SMN1; SMN2RAB9AMAPTKDM4E
SCHEMBL915037 0.81 CYP3A4 (0.48) MAP4K4SMN1; SMN2RAB9AMAPTKDM4E
SCHEMBL29733564 0.80 ABL1 (0.51) MAPTKDM4EHPGDIKBKETBK1
SCHEMBL914850 0.80 ABL1 (0.51) MAPTKDM4EHPGDIKBKETBK1
SCHEMBL15081394 0.80 SMN1; SMN2 (0.39) SMN1; SMN2PIK3CBKDM4EIKBKETBK1
SCHEMBL4971916 0.80 MAPK1 (0.40) MAPK1PTK2SMN1; SMN2RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090834-A1 SELECTIVE AZOLE PDE10A INHIBITOR COMPOUNDS PFIZER INC 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090834-A1 SELECTIVE AZOLE PDE10A INHIBITOR COMPOUNDS PDE5A, PDE3B, PDE12 SCN9A 799/4885SCN2A 1927/4885SCN3A 1173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.